CREBBP and neoplasm: Gene activation by CIC::DUX4 requires CBP and/or p300, as drug inhibition of CBP and p300 reverses the regulatory circuitry of the disease, alters the expression of oncogenic pathways and reduces xenograft tumor burden (Bosnakovski et al., 2021).